Blog of the week

 

FREE BLOG Innovation stands to be the loser in Germany’s elections

Germany's exuberant health minister Jens Spahn is unlikely to stay in post after the country's elections in September. People in the market say that his likely successors are less progressive, innovative and charismatic, which could end the streak of some of the boldest healthcare reforms we've ever seen. That could have repercussions across Europe.

FREE BLOG HMOs are the key to Israel’s vaccine success

Israel's HMOs have already transformed health risk predictions in Israel through big data analysis. Now, the systems' abilities to integrate messaging and data is pushing the country to the top of the COVID-19 vaccine league table. 

FREE BLOG The main themes of HBI 2020

Massive uncertainty, new relationships with governments, a huge acceleration in digital and roll-up opportunities were the themes that out of HBI 2020. 

FREE BLOG 2020: It was all about the C words

There was a lot of optimism around at the start of 2020. Operators and investors we spoke to had a 'C' word on their lips. That word was consolidation. Whether it was the enticing prospect of consolidating the €26bn dental market, or IPOing the world's most internationally diversified for-profit service operators, HBI's digital pages were brimming with plans. Another 'C' word, sadly, had a different idea.

FREE BLOG Health care M&A in 2021 – anyone’s guess

These are strange times. Two of the largest players in Europe are likely to IPO before the end of 2020. Meanwhile, advisers expect secondary sales to other funds run by the same PE house to account for up to half all sales.

FREE BLOG Telehealth: The best is yet to come but should platforms be owned by the state?

The use of telehealth peaked with the pandemic and is now tailing off across most of Europe. Most of the medical profession got stuck using 'primitive telehealth' like Skype so didn't see its full productivity potential. Austria has neglected the market providers and started to build its own - and there's a very strong argument for others to follow suit.

Find Us